Literature DB >> 17553047

Severe persistent pemphigoid gestationis: long-term remission with rituximab.

G Cianchini, C Masini, F Lupi, R Corona, O De Pità, P Puddu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553047     DOI: 10.1111/j.1365-2133.2007.07982.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

1.  Rituximab for autoimmune blistering diseases: recent studies, new insights.

Authors:  L Lunardon; A S Payne
Journal:  G Ital Dermatol Venereol       Date:  2012-06       Impact factor: 2.011

Review 2.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

3.  Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes.

Authors:  Babbette LaMarca; Kedra Wallace; Florian Herse; Gerd Wallukat; James N Martin; Abram Weimer; Ralf Dechend
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

4.  Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia.

Authors:  Babbette LaMarca; Marc R Parrish; Kedra Wallace
Journal:  Gend Med       Date:  2012-04-11

5.  A Systematic Review of Treatment Options and Clinical Outcomes in Pemphigoid Gestationis.

Authors:  Giovanni Genovese; Federica Derlino; Amilcare Cerri; Chiara Moltrasio; Simona Muratori; Emilio Berti; Angelo Valerio Marzano
Journal:  Front Med (Lausanne)       Date:  2020-11-20

Review 6.  Off-Label Uses of Rituximab in Dermatology.

Authors:  Connor Cole; Kyle T Amber
Journal:  Curr Dermatol Rep       Date:  2022-10-06

7.  Pemphigoid gestationis: Clinical and histologic features of twenty-three patients.

Authors:  Z Hallaji; H Mortazavi; S Ashtari; A Nikoo; M Abdollahi; M Nasimi
Journal:  Int J Womens Dermatol       Date:  2016-12-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.